177 related articles for article (PubMed ID: 23536305)
1. Genomic and functional characterizations of phosphodiesterase subtype 4D in human cancers.
Lin DC; Xu L; Ding LW; Sharma A; Liu LZ; Yang H; Tan P; Vadgama J; Karlan BY; Lester J; Urban N; Schummer M; Doan N; Said JW; Sun H; Walsh M; Thomas CJ; Patel P; Yin D; Chan D; Koeffler HP
Proc Natl Acad Sci U S A; 2013 Apr; 110(15):6109-14. PubMed ID: 23536305
[TBL] [Abstract][Full Text] [Related]
2. Reactivation of cAMP Pathway by PDE4D Inhibition Represents a Novel Druggable Axis for Overcoming Tamoxifen Resistance in ER-positive Breast Cancer.
Mishra RR; Belder N; Ansari SA; Kayhan M; Bal H; Raza U; Ersan PG; Tokat ÜM; Eyüpoğlu E; Saatci Ö; Jandaghi P; Wiemann S; Üner A; Cekic C; Riazalhosseini Y; Şahin Ö
Clin Cancer Res; 2018 Apr; 24(8):1987-2001. PubMed ID: 29386221
[No Abstract] [Full Text] [Related]
3. Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIF.
Pullamsetti SS; Banat GA; Schmall A; Szibor M; Pomagruk D; Hänze J; Kolosionek E; Wilhelm J; Braun T; Grimminger F; Seeger W; Schermuly RT; Savai R
Oncogene; 2013 Feb; 32(9):1121-34. PubMed ID: 22525277
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of oncogenic cAMP-specific phosphodiesterase 4D by miR-139-5p in response to p53 activation.
Cao B; Wang K; Liao JM; Zhou X; Liao P; Zeng SX; He M; Chen L; He Y; Li W; Lu H
Elife; 2016 Jul; 5():. PubMed ID: 27383270
[TBL] [Abstract][Full Text] [Related]
5. Expression of phosphodiesterase 4D (PDE4D) is regulated by both the cyclic AMP-dependent protein kinase and mitogen-activated protein kinase signaling pathways. A potential mechanism allowing for the coordinated regulation of PDE4D activity and expression in cells.
Liu H; Palmer D; Jimmo SL; Tilley DG; Dunkerley HA; Pang SC; Maurice DH
J Biol Chem; 2000 Aug; 275(34):26615-24. PubMed ID: 10851231
[TBL] [Abstract][Full Text] [Related]
6. Phosphodiesterase 4D inhibitors limit prostate cancer growth potential.
Powers GL; Hammer KD; Domenech M; Frantskevich K; Malinowski RL; Bushman W; Beebe DJ; Marker PC
Mol Cancer Res; 2015 Jan; 13(1):149-60. PubMed ID: 25149359
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of TPL2 by interferon-α suppresses bladder cancer through activation of PDE4D.
Qiang Z; Zhou ZY; Peng T; Jiang PZ; Shi N; Njoya EM; Azimova B; Liu WL; Chen WH; Zhang GL; Wang F
J Exp Clin Cancer Res; 2018 Nov; 37(1):288. PubMed ID: 30482227
[TBL] [Abstract][Full Text] [Related]
8. Human PDE4D isoform composition is deregulated in primary prostate cancer and indicative for disease progression and development of distant metastases.
Böttcher R; Dulla K; van Strijp D; Dits N; Verhoef EI; Baillie GS; van Leenders GJ; Houslay MD; Jenster G; Hoffmann R
Oncotarget; 2016 Oct; 7(43):70669-70684. PubMed ID: 27683107
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of phosphodiesterase 4D decreases the malignant properties of DLD-1 colorectal cancer cells by repressing the AKT/mTOR/Myc signaling pathway.
Kim DU; Nam J; Cha MD; Kim SW
Oncol Lett; 2019 Mar; 17(3):3589-3598. PubMed ID: 30867802
[TBL] [Abstract][Full Text] [Related]
10. Splice variants of the cyclic nucleotide phosphodiesterase PDE4D are differentially expressed and regulated in rat tissue.
Richter W; Jin SL; Conti M
Biochem J; 2005 Jun; 388(Pt 3):803-11. PubMed ID: 15717866
[TBL] [Abstract][Full Text] [Related]
11. Differential expression and function of phosphodiesterase 4 (PDE4) subtypes in human primary CD4+ T cells: predominant role of PDE4D.
Peter D; Jin SL; Conti M; Hatzelmann A; Zitt C
J Immunol; 2007 Apr; 178(8):4820-31. PubMed ID: 17404263
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA 494 increases chemosensitivity to doxorubicin in gastric cancer cells by targeting phosphodiesterases 4D.
Peng QP; Du DB; Ming Q; Hu F; Wu ZB; Qiu S
Cell Mol Biol (Noisy-le-grand); 2018 Dec; 64(15):62-66. PubMed ID: 30672438
[TBL] [Abstract][Full Text] [Related]
13. Exome sequencing identifies PDE4D mutations as another cause of acrodysostosis.
Michot C; Le Goff C; Goldenberg A; Abhyankar A; Klein C; Kinning E; Guerrot AM; Flahaut P; Duncombe A; Baujat G; Lyonnet S; Thalassinos C; Nitschke P; Casanova JL; Le Merrer M; Munnich A; Cormier-Daire V
Am J Hum Genet; 2012 Apr; 90(4):740-5. PubMed ID: 22464250
[TBL] [Abstract][Full Text] [Related]
14. Identification of PDE4D as a proliferation promoting factor in prostate cancer using a Sleeping Beauty transposon-based somatic mutagenesis screen.
Rahrmann EP; Collier LS; Knutson TP; Doyal ME; Kuslak SL; Green LE; Malinowski RL; Roethe L; Akagi K; Waknitz M; Huang W; Largaespada DA; Marker PC
Cancer Res; 2009 May; 69(10):4388-97. PubMed ID: 19401450
[TBL] [Abstract][Full Text] [Related]
15. BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition.
Haq R; Yokoyama S; Hawryluk EB; Jönsson GB; Frederick DT; McHenry K; Porter D; Tran TN; Love KT; Langer R; Anderson DG; Garraway LA; Duncan LM; Morton DL; Hoon DS; Wargo JA; Song JS; Fisher DE
Proc Natl Acad Sci U S A; 2013 Mar; 110(11):4321-6. PubMed ID: 23447565
[TBL] [Abstract][Full Text] [Related]
16. Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A splice variant.
Erdogan S; Houslay MD
Biochem J; 1997 Jan; 321 ( Pt 1)(Pt 1):165-75. PubMed ID: 9003416
[TBL] [Abstract][Full Text] [Related]
17. Phosphodiesterase 4D Depletion/Inhibition Exerts Anti-Oncogenic Properties in Hepatocellular Carcinoma.
Ragusa F; Panera N; Cardarelli S; Scarsella M; Bianchi M; Biagioni S; Giorgi M; Alisi A; Massimi M
Cancers (Basel); 2021 May; 13(9):. PubMed ID: 34062786
[TBL] [Abstract][Full Text] [Related]
18. Comparison of recombinant human PDE4 isoforms: interaction with substrate and inhibitors.
Saldou N; Obernolte R; Huber A; Baecker PA; Wilhelm R; Alvarez R; Li B; Xia L; Callan O; Su C; Jarnagin K; Shelton ER
Cell Signal; 1998 Jun; 10(6):427-40. PubMed ID: 9720765
[TBL] [Abstract][Full Text] [Related]
19. Ischemia-induced increase in microvascular phosphodiesterase 4D expression in rat hippocampus associated with blood brain barrier permeability: effect of age.
He Z; He B; Behrle BL; Fejleh MP; Cui L; Paule MG; Greenfield LJ
ACS Chem Neurosci; 2012 Jun; 3(6):428-32. PubMed ID: 22860212
[TBL] [Abstract][Full Text] [Related]
20. Aberrant DNA Methylation of Phosphodiesterase [corrected] 4D Alters Airway Smooth Muscle Cell Phenotypes.
Lin AH; Shang Y; Mitzner W; Sham JS; Tang WY
Am J Respir Cell Mol Biol; 2016 Feb; 54(2):241-9. PubMed ID: 26181301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
